都市激情在线亚洲国产91_欧美日韩国产国语对白_av成人毛片在线免费观看_少妇爆乳无码专区网站_亚洲Aⅴ无码吞精久久AV_亚洲AV毛片一区无码日韩_国产成人精品1024视频网站_最新综艺节目国产精品喷浆_国产在线拍揄自揄视频网站_天天少妇被猛烈进入在线播放

<nav id="g0ggg"><sup id="g0ggg"></sup></nav>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

公车痴汉媚药强抹在线观看 | 免费精品美女久久久久久久久久 | 欧美综合自拍亚洲综合图 | 亚洲日本一区二区三区在线不卡 | 内射无码专区久久亚洲 | 午夜视频在线观看国产 | 蜜桃精品免费久久久久影院 | 久久精品极品盛宴观看 | 欧美一级做暖暖视频在线观看 | 国产精品三P一区二区视频最近高清中文字幕免费MV | 欧美一级A片一级做a | 日韩精品无码一区二区免费A片 | 国产美女视频网站 | 少妇爆乳无码av无码专区在 | 天天躁日日躁狠狠躁性色AVQ | 特级做A爰片毛片免费看108 | 人人妻人人爽人人澡欧美二区 | 99久久国产精品成人观看 | 国产a级三级三级成人国产一级婬片 | 久久影院午夜理论片无码 | 九九热线有精品免费观看 | 成人无遮挡免费网站视频在线观看 | 精品日韩二区三区精品视频 | 久99久热只有精品国产99 | 国产乱子伦精品无码码专区 | 国产专区日韩精品欧美色 | 欧美高清在线视频一区二区 | 91精品国产人成网站 | 欧美两性人xxxx高清免费 | 欲色aV无码一区二区人妻 | 亚洲国产另类久久久精品小说 | 日本欧美视频在线 | 久久综合亚洲鲁鲁五月天欧美 | 亚欧精品一区二区三区四区 | 成年女人18级毛片毛片免费观看 | 免费人成视频在线看片 | 男女高潮又爽又黄又无遮挡 | 可以在线观看的黄色网址 | 黄色毛片在线观看 | 色se01短视频永久免费 | 真实亲子乱一区二区三区 |